Application-based Perioperative Management of the Radical Cystectomy Patient
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- Compliance using LST app at home
研究概览
简要总结
The purpose of this study is to learn whether it is feasible to use the LifeScience Technologies application (LST app) in patients undergoing radical cystectomy with the eventual goal to reduce complications and readmissions to the hospital after surgery.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of recurrent Non-muscle invasive bladder cancer (NMIBC) or Muscle-invasive Bladder Cancer (MIBC) and are candidates for radical cystectomy
- •Subjects must have an internet connection and be able and willing to use an applicable device. If patients do not have an applicable device, they must be willing to borrow an iPad from the study team (to be returned at the conclusion of the study).
排除标准
- •No internet access
研究组 & 干预措施
LST App
Participants will use the LifeScience Technologies application (LST app) before surgery, and post surgery. Participants will use the app as an educational tool to learn more about their surgery. Participants will also answer questions about themselves in the app.
干预措施: LifeScience Technologies application (Other)
结局指标
主要结局
Compliance using LST app at home
时间窗: 90 Days
The LST app logs user activity. The study team will track user compliance with completing forms and questions within the application.
次要结局
- Patient-generated subjective global assessment (PG-SGA)(Baseline)
- Count of readmissions(Day 90)
- Edmonton Frail Scale (EFS)(Baseline)
- Physician Office/Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) Survey Research (HealthStream™)(Change from Baseline to Day 90)
